We're moving to rndsystems.com. Come with us!

After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.

Blogs for February 2022

Synthetic Biotic Medicine as Immunotherapy Against Cancer: Evidence From Arginine-Producing Engineered Bacteria

Tuesday, February 1, 2022 - 09:12
3D banner image showing example of pathogenic bacteria.

By Jamshed Arslan, Pharm D, PhD

What do nuts, dairy and red meat have in common? In addition to the fact that they are all edible, one of the answers is L-arginine. This amino acid improves T cell’s response against tumor cells, which typically have low concentration of L-arginine. Increasing L-arginine intra-tumorally, in turn, increases the effect of immunotherapy drugs called immune checkpoint inhibitors (ICIs). To understand ICIs, consider two examples of...


Blog Topics


Archives